Your browser doesn't support javascript.
loading
Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
Hagel, Stefan; Fiedler, Sandra; Hohn, Andreas; Brinkmann, Alexander; Frey, Otto R; Hoyer, Heike; Schlattmann, Peter; Kiehntopf, Michael; Roberts, Jason A; Pletz, Mathias W.
Afiliação
  • Hagel S; Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany. stefan.hagel@med.uni-jena.de.
  • Fiedler S; Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany. stefan.hagel@med.uni-jena.de.
  • Hohn A; Center for Clinical Studies, Jena University Hospital, Jena, Germany.
  • Brinkmann A; Department of Anaesthesiology and Intensive Care Medicine, University Hospital of Cologne, Cologne, Germany.
  • Frey OR; Department of Anaesthesiology and Intensive Care Medicine, General Hospital of Heidenheim, Heidenheim, Germany.
  • Hoyer H; Department of Pharmacy, General Hospital of Heidenheim, Heidenheim, Germany.
  • Schlattmann P; Institute of Medical Statistics, Computer Sciences and Data Sciences, Jena University Hospital, Jena, Germany.
  • Kiehntopf M; Institute of Medical Statistics, Computer Sciences and Data Sciences, Jena University Hospital, Jena, Germany.
  • Roberts JA; Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
  • Pletz MW; Department of Clinical Chemistry and Laboratory Medicine, Jena University Hospital, Jena, Germany.
Trials ; 20(1): 330, 2019 Jun 06.
Article em En | MEDLINE | ID: mdl-31171029
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monitoramento de Medicamentos / Sepse / Combinação Piperacilina e Tazobactam / Antibacterianos Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monitoramento de Medicamentos / Sepse / Combinação Piperacilina e Tazobactam / Antibacterianos Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article